INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2017

An alkaline diet along with EGFR-TKI therapy was evaluated in 11 patients with EGFR mutation-positive NSCLC.

Eleven advanced or recurrent NSCLC patients with EGFR mutations who received EGFR-TKI therapy after being instructed to follow an alkaline diet were retrospectively evaluated. The median progression-free survival and overall survival were 19.5 (range = 3.1-33.8) and 28.5 (range = 15.4-46.6) months, respectively. The average dosage of EGFR-TKI was 56±22% of the standard dosage. Urine pH increased significantly after the alkaline diet from 6.00±0.38 to 6.95±0.55 (p < 0.05).

Shows an association, not proof of cause and effect.

Study type
Retrospective cohort study
Who was studied
11 advanced or recurrent NSCLC patients with EGFR mutations
What was measured
Progression-free survival, overall survival, EGFR-TKI dosage, and urine pH

THE PAPER

Effects of an Alkaline Diet on EGFR-TKI Therapy in EGFR Mutation-positive NSCLC.

Hamaguchi R, Okamoto T, Sato M, Hasegawa M, Wada H. Anticancer Res, 2017.

PubMed 28870946 ↗DOI 10.21873/anticanres.11934 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.